[Effect of naprosin on the clinical picture and selected biochemical parameters in degenerative diseases of the peripheral joints].
D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000037:antagonists & inhibitors; D000469:Alkaline Phosphatase / Q000037:antagonists & inhibitors; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007596:Joints / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D009288:Naproxen / Q000627:therapeutic use*; D010003:Osteoarthritis / Q000188:drug therapy* / Q000201:enzymology
D000893:Anti-Inflammatory Agents; D009288:Naproxen; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase
Wpływ naprosynu na obraz kliniczny i wybrane parametry biochemiczne w chorobie zwyrodnieniowej stawów obwodowych.